Position in OMER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,214,400
+$196,485 QoQ
Shares Held
115,000
+94.1% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 2.1739130434782608.ToString("F0")%
Shared 0.ToString("F0")%
None 97.82608695652173.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ancora Advisors LLC holds $4,503,700 across 42 Biotechnology names. OMER ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
This page
|
115,000 | $1,214,400 | |
| 2 | GLSI |
Greenwich LifeSciences, Inc.
|
37,500 | $900,750 | |
| 3 | CRVS |
Corvus Pharmaceuticals, Inc.
|
54,768 | $801,255 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,050 | $468,867 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,016 | $191,041 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,391 | $179,540 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
20,000 | $153,400 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
4,316 | $93,916 |
All Filings in OMER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,214,400 | 115,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,017,915 | 59,250 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $12,300 | 3,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,400 | 5,800 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $47,676 | 5,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $847,704 | 85,800 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $29,973 | 7,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,833 | 10,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $408,941 | 118,534 | Shares | Other | 2024-05-16 | |
| 2023-12-31 | $533,084 | 163,023 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $613,267 | 210,023 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $927,781 | 170,548 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,085,853 | 233,517 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $732,277 | 324,017 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $459,024 | 145,722 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $773,305 | 281,202 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $669,885 | 111,462 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $937,410 | 145,787 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,853,017 | 134,374 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,994,110 | 134,374 | Shares | Other | 2021-11-12 | |
| 2020-12-31 | $476,285 | 33,330 | Shares | Other | 2021-11-12 | |
| 2020-09-30 | $336,996 | 33,333 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||